4901 - 4925 of 8404 Results
Title
Year
- Pharmacokinetics and Biomarker Changes in NILO-PD, A Phase 2A Study of Nilotinib in Patients with Moderate to Advance Parkinson’s Disease (4418)2020RESTRICTEDTitle: Pharmacokinetics and Biomarker Changes in NILO-PD, A Phase 2A Study of Nilotinib in Patients with Moderate to Advance Parkinson’s Disease (4418)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 94Issue #: 15_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.94.15_supplement.4418Citation Count: 0
-
RESTRICTEDTitle: PPMI 2.O New Science/New Cohorts - Transforming PPMI (2490)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 94Issue #: 15_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.94.15_supplement.2490Citation Count: 6
-
-
RESTRICTEDTitle: Validation of Fox Insight Cohort via Virtual Research Visits (4749)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 94Issue #: 15_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.94.15_supplement.4749Citation Count: 1
-
OPENTitle: White Matter Hyperintensities Related to Parkinson's Disease Executive FunctionJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 7Issue #: 6Start Page: 629End Page: 638Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mdc3.12956Best OA location URL: https://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12956Citation Count: 46
- A Comprehensive Review of Brain Connectomics and Imaging to Improve Deep Brain Stimulation Outcomes2020RESTRICTEDTitle: A Comprehensive Review of Brain Connectomics and Imaging to Improve Deep Brain Stimulation OutcomesJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 5Start Page: 741End Page: 751Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28045Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556988Citation Count: 41
- Investigation of pathology, expression and proteomic profiles in human TREM2 variant postmortem brains with and without Alzheimer’s disease2020OPENTitle: Investigation of pathology, expression and proteomic profiles in human TREM2 variant postmortem brains with and without Alzheimer’s diseaseJournal Name: Brain PathologyPublisher: WileyVol: 30Issue #: 4Start Page: 794End Page: 810Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1111/bpa.12842Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bpa.12842Citation Count: 12
-
RESTRICTEDTitle: Rare Variants in Specific Lysosomal Genes Are Associated With Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 7Start Page: 1245End Page: 1248Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28037Citation Count: 49
-
OPENTitle: Variants in the Niemann–Pick type C gene NPC1 are not associated with Parkinson's diseaseJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 93Issue #:Start Page: 143.e1End Page: 143.e4Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2020.03.021Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7302975Citation Count: 18
-
OPENTitle: Binding of the Human 14-3-3 Isoforms to Distinct Sites in the Leucine-Rich Repeat Kinase 2Journal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2020.00302Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2020.00302/pdfCitation Count: 54
-
RESTRICTEDTitle: Corticobasal Degeneration Reveals Its Signature by Tau StrainsJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 6Start Page: 934End Page: 934Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28054Citation Count: 0
-
OPENTitle: Benign SLC39A14 Course of Dystonia‐Parkinsonism Secondary to Inherited Manganese AccumulationJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 7Issue #: 5Start Page: 569End Page: 570Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12947Best OA location URL: https://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12947Citation Count: 7
-
OPENTitle: Impact of the COVID‐19 Pandemic on Parkinson's Disease and Movement DisordersJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 5Start Page: 711End Page: 715Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28067Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28067Citation Count: 156
-
OPENTitle: Impact of the COVID‐19 Pandemic on Parkinson's Disease and Movement DisordersJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 7Issue #: 4Start Page: 357End Page: 360Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12953Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12953Citation Count: 53
-
RESTRICTEDTitle: Multiomics Analyses Identify Genes and Pathways Relevant to Essential TremorJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 7Start Page: 1153End Page: 1162Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28031Citation Count: 15
- Phenomenology and Management of Subthalamic Stimulation‐Induced Dyskinesia in Patients With Isolated Dystonia2020OPENTitle: Phenomenology and Management of Subthalamic Stimulation‐Induced Dyskinesia in Patients With Isolated DystoniaJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 7Issue #: 5Start Page: 548End Page: 551Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12946Best OA location URL: https://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12946Citation Count: 5
-
OPENTitle: Reply to Gender Differences in Functional Movement Disorders: Sociocultural or Biological?Journal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 7Issue #: 4Start Page: 480End Page: 481Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12950Best OA location URL: https://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12950Citation Count: 0
- Virus Bioresistor (VBR) for Detection of Bladder Cancer Marker DJ-1 in Urine at 10 pM in One Minute2020OPENTitle: Virus Bioresistor (VBR) for Detection of Bladder Cancer Marker DJ-1 in Urine at 10 pM in One MinuteJournal Name: Analytical ChemistryPublisher: American Chemical Society (ACS)Vol: 92Issue #: 9Start Page: 6654End Page: 6666Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acs.analchem.0c00534Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7266010Citation Count: 26
-
RESTRICTEDTitle: Missing heritability in Parkinson’s disease: the emerging role of non-coding genetic variationJournal Name: Journal of Neural TransmissionPublisher: Springer Science and Business Media LLCVol: 127Issue #: 5Start Page: 729End Page: 748Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00702-020-02184-0Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00702-020-02184-0.pdfCitation Count: 28
-
RESTRICTEDTitle: Advantages and Recent Developments of Autologous Cell Therapy for Parkinson’s Disease PatientsJournal Name: Frontiers in Cellular NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fncel.2020.00058Best OA location URL: https://www.frontiersin.org/articles/10.3389/fncel.2020.00058/pdfCitation Count: 28
- Associations of Lower Caffeine Intake and Plasma Urate Levels with Idiopathic Parkinson’s Disease in the Harvard Biomarkers Study2020OPENTitle: Associations of Lower Caffeine Intake and Plasma Urate Levels with Idiopathic Parkinson’s Disease in the Harvard Biomarkers StudyJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 10Issue #: 2Start Page: 505End Page: 510Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jpd-191882Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7416447Citation Count: 39
- Autoimmune hemolytic anemia, demyelinating relapse, and AQP1 antibodies after alemtuzumab infusion2020OPENTitle: Autoimmune hemolytic anemia, demyelinating relapse, and AQP1 antibodies after alemtuzumab infusionJournal Name: Neurology Neuroimmunology & NeuroinflammationPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 7Issue #: 3Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1212/nxi.0000000000000711Best OA location URL: https://nn.neurology.org/content/nnn/7/3/e711.full.pdfCitation Count: 11
- Combined mGlu2 orthosteric stimulation and positive allosteric modulation alleviates l-DOPA-induced psychosis-like behaviours and dyskinesia in the parkinsonian marmoset2020RESTRICTEDTitle: Combined mGlu2 orthosteric stimulation and positive allosteric modulation alleviates l-DOPA-induced psychosis-like behaviours and dyskinesia in the parkinsonian marmosetJournal Name: Journal of Neural TransmissionPublisher: Springer Science and Business Media LLCVol: 127Issue #: 7Start Page: 1023End Page: 1029Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00702-020-02185-zCitation Count: 11
- Does Developmental Variability in the Number of Midbrain Dopamine Neurons Affect Individual Risk for Sporadic Parkinson’s Disease?2020RESTRICTEDTitle: Does Developmental Variability in the Number of Midbrain Dopamine Neurons Affect Individual Risk for Sporadic Parkinson’s Disease?Journal Name: Journal of Parkinson's DiseasePublisher: IOS PressVol: 10Issue #: 2Start Page: 405End Page: 411Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-191877Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd191877?id=journal-of-parkinsons-disease%2Fjpd191877Citation Count: 19
- Impact of depressive symptoms on self-perceived severity of autonomic dysfunction in multiple system atrophy: relevance for patient-reported outcomes in clinical trials2020OPENTitle: Impact of depressive symptoms on self-perceived severity of autonomic dysfunction in multiple system atrophy: relevance for patient-reported outcomes in clinical trialsJournal Name: Clinical Autonomic ResearchPublisher: Springer Science and Business Media LLCVol: 30Issue #: 3Start Page: 215End Page: 221Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s10286-020-00681-6Best OA location URL: https://europepmc.org/articles/pmc7341538?pdf=renderCitation Count: 12